IP Verse

Michalski Httermann & Partner competitive analysis

Latest oppositions filed by Michalski Httermann & Partner

Explore patent oppositions filed by Michalski Httermann & Partner against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
EP4255973
Nanocellular Expanded Polymer Beads, Method Of Manufacture And UsesCELLMAT SLJul 29, 2025
EP3889181
Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJan 24, 2025
EP2872837
RefrigeratorREMIS GESELLSCHAFT FR ENTWICKLUNG UND VERTRIEB VON TECHNISCHEN ELEMENTEN KLNJan 9, 2025
EP3630946
Cell Culture MethodsUCB BIOPHARMADec 20, 2024
EP3818078
Methods Of Producing Recombinant ProteinsBRISTOL MYERS SQUIBBNov 28, 2024
EP3515465
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALSNov 7, 2024
EP3283059
Method For Producing Rna CompositionsCUREVACOct 3, 2024
EP4011915
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSJul 8, 2024
EP3803047
A Method For Determining A Parameter Of A Flow Of A Produced Fluid In A WellSCANWELL TECHNOLOGYMay 2, 2024
EP3911354
Aav-Mediated Gene Therapy Restoring The Otoferlin GeneCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSApr 19, 2024

Latest PTAB cases involving Michalski Httermann & Partner

Discover the latest PTAB cases involving Michalski Httermann & Partner, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Michalski Httermann & Partner with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MICHALSKI HTTERMANN & PARTNER26 - - -
GENENTECH - 122 - 66
IMMUNOCORE - 13 - -
REGENERON PHARMACEUTICALS38121932